No Data
Jiangsu Yuyue Medical Equipment & Supply (002223): The year-on-year growth rate of revenue in the third quarter has returned to positive, and sales of the new generation CGM have achieved rapid expansion.
Event: On October 26, the company released the third quarter report of 2024: The revenue for the first three quarters of 2024 was 6.028 billion yuan, a year-on-year decrease of 9.53%; net income attributable to the parent company was 1.532 billion yuan, year-on-year.
Sinolink Securities: The advantage of "price + medical insurance" brings a breakthrough in CGM volume. Focus on the expansion of medical instruments in the European and American markets.
Europe and the United States occupy more than two-thirds of the global CGM market share, and the average selling price of CGM products is significantly higher compared to domestic prices. If domestic companies can expand overseas markets, they will unlock greater demand and higher price levels.
Jiangsu Yuyue Medical Equipment & Supply (002223): Q3 revenue growth rate improved, with some increase in expenses.
Event: jiangsu yuyue medical equipment & supply announced its performance for the third quarter of 2024. In Q1-3 24, the company achieved revenue of 6.03 billion yuan (a decrease of 9.5% year-on-year), net income attributable to the parent company was 1.53 billion yuan (a decrease of 30.1% year-on-year), net profit attributable to the parent company after deduction of non-recurring gains and losses
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Jiangsu Yuyue Medical Equipment & Supply (002223): Quarterly revenue turns positive, long-term bullish on high-quality symbols in the aging track.
Investment Highlights: In 2024, the company announced that in the first three quarters, the company achieved total operating income of 6.028 billion yuan (-9.53%, representing year-on-year growth rate, the same below), with a net income attributable to the parent company of 1.532 billion yuan (-30.09%.
Jiangsu Yuyue Medical Equipment & Supply (002223): Performance remains robust under the base effect, bullish on the release of multiple new series products such as respiratory and blood glucose products.
Event: The company released the third-quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 6.028 billion yuan, a year-on-year decrease of 9.53%, and net income attributable to owners of the parent company of 1.532 billion yuan, a year-on-year decrease of 30.09%.
No Data
No Data